Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 66 for:    "Leukemia, Acute Lymphoblastic" | "Sargramostim"

Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00053131
Recruitment Status : Completed
First Posted : January 28, 2003
Last Update Posted : March 8, 2011
Sponsor:
Information provided by:
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2004
Actual Study Completion Date : February 2004